期刊文献+

活血化瘀方对乳腺增生病患者血管内皮生长因子及碱性成纤维细胞生长因子的影响 预览 被引量:9

Effect of blood-activating and stasis-dissolving prescription on vascular endothelial growth factor and basic fibroblast growth factors of patients with cyclomastopathy
在线阅读 免费下载
收藏 分享 导出
摘要 目的观察活血化瘀方对乳腺增生病患者血管内皮生长因子(VEGF)及碱性成纤维细胞生长因子(bFGF)的影响和临床疗效。方法将88例乳腺增生病患者随机分为2组,治疗组60例予活血化瘀方,对照组28例予西医常规治疗。2组均治疗3个疗程,随访3个月。并选择同期健康者30例为正常对照组。采用酶联免疫法测定3组治疗前后血清VEGF及bFGF变化,统计临床疗效。结果治疗组总有效率91.67%,对照组总有效率89.29%,2组总有效率比较差异无统计学意义(P〉0.05),疗效相当。2组治疗前VEGF及bFGF含量均高于正常对照组(P〈0.05)。2组治疗后VEGF及bFGF含量均较本组治疗前明显降低(P〈0.05),而组间比较差异无统计学意义(P〉0.05)。2组治疗后VEGF含量与正常对照组相当(P〉0.05),bFGF仍高于正常对照组(P〉0.05)。结论 VEGF、bFGF在乳腺增生病中过度表达,提示血管生成是其发生发展的重要环节,活血化瘀方可降低患者血清中VEGF、bFGF含量,阻断血管生成,促使病灶消散、吸收,为治疗乳腺增生病的有效方药。 Objective To investigate the effect and clinical efficacy of blood-activating and stasis-dissolving prescription on vascular endothelial growth factor and basic fibroblast growth factors of patients with cyclomastopathy.Methods 88 patients with cyclomastopathy were randomly divided into two groups.Treatment group received blood-activating and stasis-dissolving prescription.Control group received conventional western therapy.30 health cases were as normal control group.The changes of VEGF and bFGF in serum in three groups were measured by ELISA.Results The total effective rate in treatment group was 91.67% and 89.29% in control group.There was no difference between two groups on the total effective rate(P〉0.05).VEGF and bFGF before treatment in control group and treatment group were higher than those in normal control group(P〈0.05).VEGF and bFGF after treatment were decreased as compared with those before treatment in two groups(P〈0.05).There was no difference between two groups on VEGF and bFGF after treatment(P〉0.05).VEGF levels in two groups after treatment were pretty as those of normal control group(P〉0.05).Conclusion The over-expression of VEGF and bFGF in cyclomastopathy suggested that angiogenesis is an important part of the development of cyclomastopathy.Blood-activating and stasis-dissolving prescription can reduce the contents of VEGF and bFGF in serum of patients,can block angiogenesis,promote lesion dissipation,absorption,and is an effective prescription for the treatment of cyclomastopathy.
作者 张培红 刘京芳 马学伟 裴林 ZHANG Peihong,LIU Jingfang,MA Xuewei,et al.Department of Gynecology,Hebei Province Institute of Traditional Chinese Medicine,Hebei,Shijiazhuang 050031
出处 《河北中医》 2011年第12期 1786-1787,1790,共3页 Hebei Journal of Traditional Chinese Medicine
关键词 乳腺增生病 活血化瘀剂 中医疗法 血管内皮生长因子A 成纤维细胞生长因子2 Cyclomastopathy Blood-activating and stasis-dissolving prescription Therapy of traditional Chinese Medicine Vascular endothelial growth factor A Fibroblast growth factors
作者简介 张培红(1973一),女,主治医师,学士。从事妇科临床工作。 通讯作者:河北省中医药研究院内科,河北石家庄050031
  • 相关文献

参考文献10

二级参考文献31

共引文献73

同被引文献97

引证文献9

二级引证文献26

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈
新型冠状病毒肺炎防控与诊疗专栏